|
uric acid nephrolithiasis
|
DOID_580 |
|
|
Aland Island eye disease
|
DOID_0050630 |
|
|
tight binding inhibition
|
BAO_0000490 |
|
|
MTP inhibitor
|
CHEBI_72298 |
|
|
nerve growth factor stimulator
|
CHEBI_72294 |
|
|
fuel additive
|
CHEBI_62803 |
|
|
antiparathyroid drug
|
CHEBI_50827 |
|
|
primary cutaneous amyloidosis
|
DOID_0050639 |
|
|
non-competitive inhibition
|
BAO_0000485 |
|
|
uncompetitive inhibition
|
BAO_0000483 |
|
|
competitive inhibition
|
BAO_0000482 |
|
|
kcat
|
BAO_0000481 |
|
|
kon
|
BAO_0000480 |
|
|
oculocutaneous albinism
|
DOID_0050632 |
|
|
Allan-Herndon-Dudley syndrome
|
DOID_0050631 |
|
|
ocular albinism
|
DOID_0050633 |
|
|
trichomoniasis
|
DOID_1947 |
|
|
growth hormone
|
CHEBI_37845 |
|
|
partial inhibition
|
BAO_0000488 |
|
|
osteomalacia
|
DOID_10573 |
|
